See more : BHUDEVI INFRA PROJECTS LIMITED (BHUDEVI.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Hospital Corporation of China Limited (3869.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hospital Corporation of China Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Wesfarmers Limited (WES.AX) Income Statement Analysis – Financial Results
- SF Urban Properties AG (0QN6.L) Income Statement Analysis – Financial Results
- Eros Media World Plc (EMWP) Income Statement Analysis – Financial Results
- Nordea Inv European Small Cap S (NDIESCSKL1.CO) Income Statement Analysis – Financial Results
- Uniparts India Limited (UNIPARTS.NS) Income Statement Analysis – Financial Results
Hospital Corporation of China Limited (3869.HK)
About Hospital Corporation of China Limited
Hospital Corporation of China Limited, an investment holding company, engages in the operation and management of hospitals in the People's Republic of China. The company provides hospital management and consulting services to Yangsi Hospital, Cixi Hospital, and Jinhua Hospital; and general hospital services. It also engages in the wholesale of pharmaceutical products. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited is a subsidiary of Vanguard Glory Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.43B | 1.14B | 520.29M | 399.21M | 410.88M | 383.61M | 149.16M | 161.39M | 142.52M | 28.38M |
| Cost of Revenue | 1.19B | 992.07M | 306.06M | 204.89M | 237.02M | 231.48M | 61.32M | 77.77M | 41.40M | 8.16M |
| Gross Profit | 239.36M | 150.88M | 214.23M | 194.33M | 173.87M | 152.13M | 87.84M | 83.62M | 101.13M | 20.22M |
| Gross Profit Ratio | 16.77% | 13.20% | 41.17% | 48.68% | 42.32% | 39.66% | 58.89% | 51.81% | 70.96% | 71.26% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 129.23M | 95.16M | 95.87M | 51.90M | 64.54M | 63.32M | 53.71M | 28.27M | 13.20M | 7.39M |
| Selling & Marketing | 1.57M | 344.00K | 2.01M | 4.00K | 9.00K | 204.00K | 0.00 | 4.00K | 1.00K | 1.51M |
| SG&A | 130.80M | 95.50M | 97.88M | 51.90M | 64.54M | 63.53M | 53.71M | 28.27M | 13.20M | 8.90M |
| Other Expenses | -105.94M | -5.94M | -7.18M | -4.80M | -1.68M | -65.15M | -2.57M | -2.98M | -1.84M | 0.00 |
| Operating Expenses | 24.86M | 89.56M | 90.70M | 47.10M | 62.87M | 58.64M | 51.13M | 25.29M | 11.37M | 10.75M |
| Cost & Expenses | 1.21B | 1.08B | 396.76M | 251.99M | 299.88M | 290.12M | 112.45M | 103.06M | 52.76M | 18.91M |
| Interest Income | 6.90M | 8.99M | 6.73M | 18.42M | 10.59M | 1.78M | 3.93M | 423.00K | 692.00K | 700.80K |
| Interest Expense | 4.42M | 4.91M | 6.09M | 13.06M | 14.71M | 15.90M | 27.54M | 15.71M | 16.15M | 0.00 |
| Depreciation & Amortization | 62.86M | 63.28M | 41.15M | 42.90M | 43.83M | 30.35M | 6.00M | 7.15M | 6.91M | 2.45M |
| EBITDA | 283.48M | -464.44M | -401.87M | -379.86M | 254.10M | 64.14M | 42.53M | 63.51M | 96.67M | 11.90M |
| EBITDA Ratio | 19.86% | -0.64% | 32.86% | 76.08% | 61.00% | 15.40% | 28.63% | 40.61% | 67.91% | 41.94% |
| Operating Income | 214.50M | 61.32M | 129.83M | 260.81M | 177.03M | 33.85M | 37.75M | 59.40M | 90.06M | 9.45M |
| Operating Income Ratio | 15.02% | 5.36% | 24.95% | 65.33% | 43.09% | 8.82% | 25.31% | 36.80% | 63.19% | 33.29% |
| Total Other Income/Expenses | 1.71M | 5.36M | -14.03M | -35.98M | 22.25M | -15.96M | -18.53M | 1.94M | 461.00K | 726.00K |
| Income Before Tax | 216.20M | -532.63M | -449.10M | -435.82M | 195.57M | 17.88M | 19.23M | 60.09M | 90.11M | 10.18M |
| Income Before Tax Ratio | 15.14% | -46.60% | -86.32% | -109.17% | 47.60% | 4.66% | 12.89% | 37.23% | 63.23% | 35.85% |
| Income Tax Expense | 47.86M | -4.03M | -86.71M | -14.75M | 26.12M | 41.30M | 22.91M | 18.61M | 22.79M | 5.02M |
| Net Income | 131.38M | -528.60M | -362.40M | -421.07M | 150.90M | -50.49M | -13.75M | 24.07M | 50.94M | 2.48M |
| Net Income Ratio | 9.20% | -46.25% | -69.65% | -105.47% | 36.73% | -13.16% | -9.22% | 14.91% | 35.74% | 8.74% |
| EPS | 0.07 | -3.83 | -2.62 | -3.05 | 1.09 | -0.37 | -0.11 | 0.18 | 0.38 | 0.03 |
| EPS Diluted | 0.21 | -3.83 | -2.62 | -3.05 | 0.74 | -0.37 | -0.11 | 0.18 | 0.38 | 0.03 |
| Weighted Avg Shares Out | 615.89M | 138.19M | 138.19M | 138.19M | 202.85M | 137.20M | 127.17M | 133.19M | 133.19M | 97.00M |
| Weighted Avg Shares Out (Dil) | 202.16M | 138.19M | 138.19M | 138.19M | 202.85M | 137.24M | 127.17M | 133.19M | 133.19M | 97.00M |
Source: https://incomestatements.info
Category: Stock Reports